IOMM-Lee细胞
文献支持

IOMM-Lee细胞

收藏
  • ¥3000
  • BHcell(博辉生物)
  • BH-C340
  • 2025年12月04日
    avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    IOMM-Lee /IOMM-Lee 细胞系/IOMM-Lee 细胞株/IOMM-Lee 人脑膜瘤细胞

    Cell line name IOMM-Lee

    Synonyms IOMM-LEE; Iomm-Lee; IOMM Lee; IOMMLEE; IntraOsseous Malignant Meningioma-Lee

    Accession CVCL_5779

    Resource Identification Initiative To cite this cell line use: IOMM-Lee (RRID:CVCL_5779)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Population: Chinese.

    Doubling time: ~62 hours (PubMed=2234331); 18 hours (PubMed=25984343); 0.8 day (PubMed=34850056); ~22 hours (ATCC=CRL-3370).

    Omics: Array-based CGH.

    Omics: Deep exome analysis.

    Omics: shRNA library screening.

    Derived from site: In situ; Brain; UBERON=UBERON_0000955.

    Sequence variations

    Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-000629).

    Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=28552950).

    Disease Intracranial meningioma (NCIt: C4656)

    Meningioma (ORDO: Orphanet_2495)

    Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)

    Hierarchy Children:

    CVCL_HA67 (IOMM-Lee-LucNeo)

    Sex of cell Male

    Age at sampling 61Y

    Category Cancer cell line

    STR profile Source(s): ATCC=CRL-3370

     

    Markers:

    Amelogenin X

    CSF1PO 9,10

    D5S818 11,13

    D7S820 11,12

    D13S317 8,9

    D16S539 12,13

    TH01 6,7

    TPOX 8,11

    vWA 17,18

     

    Run an STR similarity search on this cell line

    Publications

    PubMed=2234331; DOI=10.1097/00006123-199009000-00008

    Lee W.-H.

    Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee.

    Neurosurgery 27:389-396(1990)

     

    PubMed=16554968; DOI=10.1007/s11060-005-9076-y

    Baia G.S., Slocum A.L., Hyer J.D., Misra A., Sehati N., VandenBerg S.R., Feuerstein B.G., Deen D.F., McDermott M.W., Lal A.

    A genetic strategy to overcome the senescence of primary meningioma cell cultures.

    J. Neurooncol. 78:113-121(2006)

     

    PubMed=18261772; DOI=10.1016/j.surneu.2007.06.031

    Ragel B.T., Couldwell W.T., Gillespie D.L., Wendland M.M., Whang K., Jensen R.L.

    A comparison of the cell lines used in meningioma research.

    Surg. Neurol. 70:295-307(2008)

     

    PubMed=25984343; DOI=10.1038/sdata.2014.35; PMCID=PMC4432652

    Cowley G.S., Weir B.A., Vazquez F., Tamayo P., Scott J.A., Rusin S., East-Seletsky A., Ali L.D., Gerath W.F.J., Pantel S.E., Lizotte P.H., Jiang G.-Z., Hsiao J., Tsherniak A., Dwinell E., Aoyama S., Okamoto M., Harrington W., Gelfand E.T., Green T.M., Tomko M.J., Gopal S., Wong T.C., Li H.-B., Howell S., Stransky N., Liefeld T., Jang D., Bistline J., Meyers B.H., Armstrong S.A., Anderson K.C., Stegmaier K., Reich M., Pellman D., Boehm J.S., Mesirov J.P., Golub T.R., Root D.E., Hahn W.C.

    Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.

    Sci. Data 1:140035-140035(2014)

     

    PubMed=28552950; DOI=10.1371/journal.pone.0178322; PMCID=PMC5446134

    Mei Y., Bi W.-Y.L., Greenwald N.F., Agar N.Y.R., Beroukhim R., Dunn G.P., Dunn I.F.

    Genomic profile of human meningioma cell lines.

    PLoS ONE 12:E0178322-E0178322(2017)

     

    PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103

    Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. 3rd, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.

    Next-generation characterization of the Cancer Cell Line Encyclopedia.

    Nature 569:503-508(2019)

     

    PubMed=34850056; DOI=10.1093/jnen/nlab111; PMCID=PMC8716066

    Uhlmann E.J., Rabinovsky R., Varma H., El Fatimy R., Kasper E.M., Moore J.M., Vega R.A., Thomas A.J., Alterman R.L., Stippler M., Anderson M.P., Uhlmann E.N., Kipper F.C., Krichevsky A.M.

    Tumor-derived cell culture model for the investigation of meningioma biology.

    J. Neuropathol. Exp. Neurol. 80:1117-1124(2021)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由博辉生物科技(广州)有限公司提供; *发表【英文论文】请标注:From Bohui Biological Technology (Guangzhou) Co., Ltd.

    图标技术资料

    资料下载:

    IOMM-Lee(BH-C340).docx 附 (下载 0 次)

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥2000
    上海匹拓生物科技有限公司
    2025年12月03日询价
    ¥3000
    上海酶研生物科技有限公司
    2025年07月13日询价
    ¥4000
    上海晶风生物科技有限公司
    2025年07月11日询价
    ¥2000
    武汉尚恩生物技术有限公司
    2025年12月09日询价
    ¥2000
    上海中乔新舟生物科技有限公司
    2025年12月05日询价
    文献支持
    IOMM-Lee细胞
    ¥3000